Clinically, several inflammatory mediators including IL-6 are proposed to increase the risk of DVT in various types of pathological conditions such as surgery, obesity, cystic fibrosis, sepsis, systemic infection, cancer, inflammatory bowel disease, and lupus (42). This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.